The MDA levels did not decrease when either apigenin or omeprazole were used as a control suggesting that AGC has an antioxidative mechanism to reduce gastric lesions. Apigenin glucuronopyranoside also decreased mucosal glutathione (GSH) levels significantly suggesting that AGC possesses free radical scavenging activity.